Загрузка...
Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia
Background: Phosphoinositide 3-kinase inhibitors (PI3Ki) are a new class of medications used to treat HR positive, HER2 negative, PIK3CA mutated advanced or metastatic breast cancer. Inhibition of PI3K, a key enzyme in the insulin signaling pathway, leads to disruption of glucose metabolism and freq...
Сохранить в:
| Опубликовано в: : | J Endocr Soc |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089671/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.803 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|